Deborah Peel, MD, knows patient data can be protected as well as leveraged for analytical research, but the infrastructure must be redesigned for granular control
Deborah Peel, MD, is the founder of Patient Privacy Rights (PPR), a national not-for-profit watchdog coalition. As a physician, she was inspired to adopt privacy as her mission in 1993 after an unnerving proposal from President Bill Clinton called for every patient encounter in America to be recorded in an electronic data-base. She was intimately familiar with the anxiety related to privacy in her own psychiatric-services practice, but the broad reach of electronic health records posed an imminent threat she just couldn't ignore.
From the very first week she began in practice, patients offered to pay for treatment out of pocket if she would agree to conceal their visits from insurance plans. A Distinguished Fellow of the American Psychiatric Assn., Dr. Peel says she didn't learn about the tremendous task of managing privacy from medical school; she learned it from her patients. Each patient has an individual expectation for how his or her privacy must be maintained, and most want extremely granular control of how health data is used, not a collective policy.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
June 19th 2025Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be available to the people who would benefit most from HIV PrEP?
Read More